Does postmenopausal estrogen withdrawal increase inflammation and intensify joint and muscle pain?

The transition to menopause and the subsequent withdrawal of estrogen trigger significant biological shifts that alter how the body regulates inflammation and processes pain signals. For postmenopausal women, these changes can fundamentally change the experience of musculoskeletal discomfort.

Clinical and effectiveness evidence

Research indicates a strong correlation between the postmenopausal state and increased pain intensity.

• Musculoskeletal Prevalence: Approximately 71% of perimenopausal women report joint and muscle pain. Postmenopausal women are 1.45 times more likely to experience moderate to severe musculoskeletal pain compared to premenopausal women (OR: 1.45).
• Cytokine Correlation: Elevated levels of pro-inflammatory cytokines, specifically interleukin-8 (IL-8), have been significantly correlated with higher pain intensity and psychological distress in postmenopausal populations.
• Pain Sensitivity: Studies using experimental stimuli, such as heat, show that postmenopausal adults exhibit heightened sensitivity alongside increased pro-inflammatory responses compared to younger cohorts.

Mechanistic explanations

The intensification of pain following estrogen withdrawal is driven by two primary pathways: the upregulation of inflammatory signaling and the modulation of pain processing in the nervous system.

• Inflammatory Signaling: Estrogen normally suppresses pro-inflammatory pathways. Its withdrawal activates the NF-κB pathway and the NLRP3 inflammasome, leading to a systemic increase in cytokines such as IL-6 and TNF-α. This state, often termed "inflamm-aging," creates a pro-inflammatory environment that sensitizes tissues.
• Pain Threshold Modulation: Estrogen acts as a "master coordinator" of pain. It typically inhibits pro-nociceptive (pain-sensing) signaling via TRPV1 and P2X3 receptors in the dorsal root ganglia and supports the endogenous opioid system in the spinal cord. While clinical data on sensory testing remains complex, the loss of these inhibitory mechanisms is a plausible driver for lowered pain thresholds.
• Cellular Shifts: Estrogen decline increases the activation of TH1 and TH17 cells, further shifting immune regulation toward a state that promotes inflammation rather than resolution.

Bottom line

Postmenopausal estrogen withdrawal shifts the body into a pro-inflammatory state and removes key neurological "brakes" on pain signaling. This combination of higher systemic inflammation and reduced inhibitory control likely explains why joint and muscle pain often feel more intense during and after the menopausal transition.